TARO-PALBOCICLIB

Identification of Taro-Palbociclib

No description

Google image searchProduct monograph

Active ingredient

palbociclib, 125 MG

DIN: 02547651

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 17-SEP-2024

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EF — Cyclin-dependent kinase (CDK) inhibitors (ATC, ATC/DDD)
• L01EF01 — PALBOCICLIB (ATC/DDD)

Reference brand drug: Ibrance

External Links for Taro-Palbociclib

Search on Google

• Taro-Palbociclib side effects
• Taro-Palbociclib dosage
• palbociclib side effects
• palbociclib dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-palbociclib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.